等待开盘 04-01 09:30:00 美东时间
+1.000
+1.36%
Scorpio Tankers Inc. reported updated average daily TCE rates for the first and second quarters of 2026, along with liquidity and debt status. The TCE rates for LR2, MR, and Handymax vessels were detailed, with coverage percentages provided. The company also announced reductions in outstanding debt, increased cash reserves, and improved net cash position, reflecting financial stability.
03-25 20:15
霍尔木兹海峡中断,商业库存与战略库存释放导致的全球原油库存快速去化,将与中东产油国高库存形成巨大“压力差”。 智通财经APP获悉,申万宏源发布研报称,霍尔木兹...
03-19 14:29
Scorpio Tankers Inc. files Form 3 as Secretary Auste Adelborg reports 6,834 common shares Scorpio Tankers reported an initial statement of beneficial ownership filed by Auste Adelborg, an officer serving as Secretary. Adelborg beneficially owned 6,834 common shares held directly. Disclaimer: This ne
03-17 21:57
Scorpio Tankers director Rayner Merrick James Forbes files initial beneficial ownership statement Scorpio Tankers reported an initial statement of beneficial ownership by Rayner Merrick James Forbes, a director. Forbes reported direct beneficial ownership of 21,999 common shares. Disclaimer: This ne
03-17 21:42
Scorpio Tankers Inc. has agreed to sell three product tankers: two 2015-built MR tankers for $35 million each and one 2015-built LR2 tanker for $60 million. These sales are expected to close in the first or second quarter of 2026. The company also entered into time charter-out agreements for two LR2 tankers, with terms of five and eight years at rates of $33,000 and $30,500 per day, respectively. The charters are set to commence in 2026's first o...
03-05 11:45
Shares of oil and gas companies are trading higher after the U.S. and Israel la...
03-02 21:55
Discipline Wins When Narratives Get Loud Markets spent the past month doing wha...
02-21 04:12
今日重点评级关注:Ascendiant Capital:维持RenovoRx"买入"评级,目标价从12.5美元升至13美元;Lake Street:维持Insight Molecular"买入"评级,目标价从8美元升至12美元
02-18 16:48
(来源:信德海事) 近日,总部位于摩纳哥的全球成品油轮巨头Scorpio Tankers在最新发布的财务报告中宣布,正式行使其在大连船舶重工集团(以下简称大船集...
02-14 18:29
今日重点评级关注:HC Wainwright & Co.:维持NovoCure"买入"评级,目标价从39美元升至47美元;HC Wainwright & Co.:维持Agios制药"买入"评级,目标价从62美元升至65美元
02-13 15:30